🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus 14mg real-world experience thread Page 3

Rybelsus 14mg real-world experience thread

mike_nyc Sat, Jun 6, 2026 at 1:42 AM 21 replies 520 viewsPage 3 of 5
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Jun 6, 2026 at 5:48 AM#11
Dr.RaviCardio said:
The gap between trial results and real-world results is consistent and it is not fraud.

Agreed, and subgroup analyses deserve particular suspicion. With enough subgroups something is significant by chance, and pre-registered subgroups are a different animal from ones found afterwards.

Last edited: Jun 6, 2026 at 7:48 AM
33 6DebRD_ATL, KristenIndy, MarkLI_maint and 30 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Jun 6, 2026 at 8:05 AM#12
HPLC_Greg said:
The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest.

Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.

34 7james_edin, FranDenver, Dr.BariatricHTX and 31 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Jun 6, 2026 at 10:21 AM#13
Dr.RaviCardio said:
The gap between trial results and real-world results is consistent and it is not fraud.

Pushing back on Dr.RaviCardio here. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: Jun 6, 2026 at 2:21 PM
35 8Dr.PulmRoch, maya_sedona, stefan_berlin and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jun 6, 2026 at 12:38 PM#14

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

36 9Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 33 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 6, 2026 at 2:55 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. No action needed from anybody.

37 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 34 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register